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Abstract The first cDNA for the translational release factor
eRF1 of ciliates was cloned from Tetrahymena thermophila. The
coding frame contained one UAG and nine UAA codons that are
reassigned for glutamine in Tetrahymena. The deduced protein
sequence is 57% identical to human eRF1. The recombinant
Tetrahymena eRF1 purified from a yeast expression system was
able to bind to yeast eRF3 as do other yeast or mammalian
eRF1s as a prerequisite step for protein termination. The
recombinant Tetrahymena eRF1, nevertheless, failed to catalyze
polypeptide termination in vitro with rat or Artemia ribosomes,
at least in part, due to less efficient binding to the heterologous
ribosomes. Stop codon specificity and phylogenetic significance
of Tetrahymena eRF1 are discussed from the conservative
protein feature.
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1. Introduction
Newly synthesized polypeptide chains are released from
peptidyl-tRNA when the ribosome encounters a stop signal
on mRNA. Translation termination requires two classes of
polypeptide release factors (RFs): one, codon-speci¢c (RF1
and RF2 in prokaryotes; eRF1 in eukaryotes) and the other,
non-speci¢c to codon (RF3 in prokaryotes; eRF3 in eukary-
otes) [1,2]. RF1 and RF2 recognize UAG/UAA and UGA/
UAA, respectively [1,3], and known eukaryotic eRF1s recog-
nize all three stop codons [1,4]. It is suggested that the codon-
speci¢c RF interacts directly with the stop codon of mRNA,
and the non-speci¢c RF mediates GTP hydrolysis in this proc-
ess [1,2,5]. However, the mechanism of how RF recognizes the
stop codon has long been unknown in spite of the discovery
of RF activity in vitro in the late 1960s. We have shed light on
this problem by ¢ndings of conserved protein motifs in pro-
karyotic and eukaryotic RFs, as well as in the C-terminal
portion of bacterial elongation factor EF-G [6]. Since the C-
terminal part of EF-G appears to mimic the shape of tRNA
[7^9], we have proposed the ’RF-tRNA mimicry’ hypothesis
in which codon-speci¢c RFs mimic a tRNA shape for binding
to the ribosome as well as an anticodon for reading the stop
codon [1,6].
Determination of polypeptide region(s) and residues of RF
that are responsible for recognition and discrimination of stop
codons is a clue to understanding the mechanism underlying
this triplet decoding. In prokaryotes, the selective recognition
of UAG and UGA by RF1 and RF2 provides us with an
experimental clue to studying the RF domain(s) and amino
acids that a¡ect the selectivity by mutational and biochemical
means [5,10].
Contrary to the bacterial RFs, the omnipotence of eRF1s in
reading the stop codons impedes the identi¢cation of the anti-
codon moiety of eRF1s in eukaryotes. It could facilitate the
study if we were able to deal with an eRF1 protein that
harbors selectivity or preference in stop codon recognition.
Potentially two ways might be possible: one, to ¢nd such an
eRF1 in nature; the other, to create it by genetic means. It
might be useful to screen for a putative eRF1 responsive to
speci¢c codon(s) in ciliates (unicellular protozoa) because
some of them are known to have reassigned UAA and
UAG (or UGA) as a sense codon instead of a stop codon
during evolution. For example, in Euplotes octacarinatus,
UGA is decoded as cysteine [11] and UAA/UAG are decoded
as glutamine in Tetrahymena thermophila [12^15]. It is tempt-
ing to speculate that these eRF1s possess selective recognition
of UAA/UAG and UGA, respectively, and do not recognize
the other(s). Unless they possess selectivity or preference in
reading these triplets, there must be a putative mechanism
behind that to have cysteinyl- or glutaminyl-tRNA win the
competition with eRF1.
Toward this aim, we cloned the eRF1 gene from T. thermo-
phila and puri¢ed the recombinant Tetrahymena eRF1 (re-
ferred to as Tt-eRF1) using the heterologous expression sys-
tem in the budding yeast, Saccharomyces cerevisiae, for the
initial characterization of Tt-eRF1. This is the ¢rst report of
cloning of an eRF1 gene from ciliates.
2. Materials and methods
2.1. Strains and media
Strains used are: T. thermophila strain CU427 [16], S. cerevisiae
YPH499 [17]. Tetrahymena was grown at 25‡C in liquid medium
containing 2% (w/v) Bacto peptone, 0.2% (w/v) yeast extract, and
0.5% (w/v) glucose. Yeast cells were grown in YPD or synthetic com-
plete (SC) media [18].
2.2. Gene manipulation
The Tt-eRF1 segment was ¢rst cloned from Tetrahymena DNA by
polymerase chain reaction (PCR) using primer 4 (5P-TTGAATTCTT-
GAA(A/T)CCATTTTCACCACC-3P) and primer 5 (5P-TAGAATTC-
GAGTATGG(C/A)ACTGC(C/A)TCTAACATTAA-3P). The N-ter-
minal and C-terminal coding sequences were ampli¢ed by the
RACE (Rapid ampli¢cation of cDNA ends) method from Tetrahy-
mena RNA using the 5P RACE System (Gibco BRL, Gaithersburg,
MD, USA) according to the manufacturer’s instructions. The 5P
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RACE products were synthesized using primer 11 (5P-ACCTCT-
ACCGTGCTTCTTG-3P) for ¢rst cDNA strand synthesis, the pair
of primer 9 (5P-TTGAATTCTTTGTATTTCCTTGGAGATTGG-3P)
and 5P-RACE Abridged Anchor Primer (5P-GGCCACGCGTCGAC-
TAGTACGGGIIGGGIIGGGIIG-3P ; Gibco BRL) for ¢rst PCR, and
the pair of primer 9 and AUAP primer (5P-GGCCACGCGTCGAC-
TAGTAC-3P ; Gibco BRL) for nested PCR. The 3P RACE products
were synthesized using oligo(dT) primer (5P-GAGGATCCGGGTAC-
CATTTTTTTTTTTTTTTTT-3P) for ¢rst cDNA strand synthesis, and
the pair of primer 8 (5P-TTGAATTCAAAGAACTCCCAATAAT-
GGTTTG-3P) and adapter primer 15 (5P-GAGGATCCGGGTAC-
CATTT-3P) for PCR. Correct 5P and 3P coding parts con¢rmed by
DNA sequencing were used to reconstruct the cDNA for Tt-eRF1 in
plasmid pALTER-1 (Promega). Site-directed substitutions of the
glutamine codon for 10 UAA/UAG codons within the coding se-
quence were performed using Altered Sites II in vitro Mutagenesis
System (Promega) and designed oligonucleotides. Other DNA or
RNA manipulations were conducted according to standard methods
[19].
2.3. Anti-Tt-eRF1 antibody
Rabbit antibody against Tt-eRF1 was prepared using the recombi-
nant Tt-eRF1 protein solubilized with 8 M urea from the aggregates
formed in Escherichia coli (to be published elsewhere).
2.4. Puri¢cation of soluble Tt-eRF1 expressed in yeast
The soluble form of the recombinant Tt-eRF1 protein was puri¢ed
from S. cerevisiae strain YPH499 transformed with the Tt-eRF1 ex-
pression plasmid pTHeRF1-4/12, a derivative of pYES2 (Invitrogen)
that contained the sense codon-manipulated Tt-eRF1 cDNA. Tt-
eRF1 was marked with a histidine (His6) tag at its N-terminus. Trans-
formants were grown at 25‡C in SC medium free of uracil supple-
mented with galactose (for induction of the GAL1 promoter), lysed by
French press in lysis bu¡er containing 50 mM NaH2PO4, pH 7.7, 300
mM NaCl, 10 mM MgCl2, 20 mM imidazole, 5 mM 2-mercaptoetha-
nol and 1 mM phenylmethylsulfonyl £uoride, and cell lysates were
prepared by low speed centrifugation. Two separate puri¢cation pro-
cedures were employed: one, to purify directly from the lysates by
a⁄nity chromatography using Ni-NTA Agarose (Qiagen) column ac-
Fig. 1. Comparison of the amino acid sequences of eukaryotic and archaebacterial release factors. The number of the amino acid position is
counted from the N-terminal Met of the human eRF1. Eukaryotic eRF1s: Hs, Homo sapiens (accession number X81625); Xl, Xenopus laevis
(Z14253); At, Arabidopsis thaliana (X69375); Sc, S. cerevisiae (X04082); Sp, S. pombe (D63883); Tt, T. thermophila (AB026195, this study).
Archaebacterial RFs: Mj, Methanococcus jannaschii (U67526); Ph, Pyrococcus horikoshii (AP000006). Identical amino acids conserved in the
majority of eRF1s are shown in black; those conserved in the second majority of eRF1s are shown in gray. Seven conserved domains A^G [6]
are shown. Asterisks indicate positions of UAA/UAG manipulated to the glutamine codon in Tt-eRF1. Positions of primers 4 and 5 are shown
by arrows.
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cording to the manufacturer’s instruction; the other, to purify from
the post-ribosomal supernatant (see below) by the same Ni-NTA af-
¢nity chromatography, followed by two sequential chromatographies
using AF-Heparin Toyopearl 650 M (Tosoh Co.) and Aº KTA Mono
Q (Pharmacia) columns. The details of puri¢cation conditions will be
published elsewhere.
2.5. In vitro eRF1 and eRF3 binding assay
Schizosaccharomyces pombe eRF1 and eRF3 derivatives, His6-Sp-
eRF1 (histidine-tagged) and GST-Sp-eRF3* (glutathione S-transfer-
ase fusion to the C-terminal two-thirds) were isolated and used for in
vitro binding assays with His6-Tt-eRF1 essentially as described pre-
viously [20].
2.6. Preparation of ribosomal and post-ribosomal fractions
The ribosomal fraction and post-ribosomal supernatants were pre-
pared according to the method by Stans¢eld et al. [21] except that
Tetrahymena and yeast cells were lysed using a French press and by
sonication coupled with freezing-thawing, respectively.
3. Results
3.1. Cloning of cDNA for Tetrahymena eRF1
Based on the multiple sequence alignment of eRF1s, we
designed three sense and four antisense degenerated primers
at conservative regions for PCR ampli¢cation. Of 12 possible
combinations of primer sets tested, the combination of pri-
mers 4 and 5 (see Fig. 1) gave rise to a 1268 bp product from
Tetrahymena DNA (data not shown). DNA sequence analysis
of this PCR product revealed that the ampli¢ed sequence
shares high polypeptide sequence homology with yeast and
mammalian eRF1s, and is interrupted by two intronic sequen-
ces of 160 and 464 bp in length as well as by three in-frame
UAA and one in-frame UAG within the predicted exon se-
quences (data not shown).
Based on the above exon information, whole cDNAs for
Tt-eRF1 were ¢rst synthesized in two overlapping 5P (603 bp)
and 3P (1305 bp) fragments from Tetrahymena RNA by 5P and
3P RACE method, and the complete sequence of putative Tt-
eRF1 was constructed by ligating them at the overlapping
unique HindIII site. The DNA sequence contained a 1308
bp open reading frame (ORF) £anked by AUG initiator
and UGA terminator codons, given that the in-frame UAA
and UAG codons are assigned as glutamine in Tetrahymena.
The putative Tt-eRF1 coding sequence contained one UAG at
codon position 239, and nine UAA at positions 8, 43, 68, 210,
221, 271, 281, 309 and 339 (Fig. 1). The deduced protein
sequence is composed of 435 amino acids (calculated molec-
ular mass 49.5 kDa) and 57% identical (and 66% similar) to
human and Xenopus eRF1 sequences.
Similarity alignments of multiple eRF1 sequences clearly
indicated that the conservative amino acids in known eRF1s
are also highly conserved in this putative Tt-eRF1 except for
some residues that are unique to this sequence (see Fig. 1).
Southern blot analyses of restriction digests of Tetrahymena
DNA showed a unique band hybridized to this cDNA probe,
showing that it is the single gene encoded in the Tetrahymena
chromosome (data not shown). Moreover, this recombinant
protein is able to bind to yeast eRF3 and associated with the
ribosome (see below). For these reasons, we believe that the
cloned cDNA encodes the unique Tetrahymena eRF1. The
nucleotide sequence data reported in this paper will appear
in the DDBJ/EMBL/GenBank nucleotide sequence databases
with accession number AB026195.
3.2. Expression and puri¢cation of Tetrahymena eRF1
To express and purify the recombinant Tt-eRF1 protein
under heterologous expression conditions, 10 UAA/UAG
triplets within the coding sequence were changed to the glu-
tamine codon CAA or CAG by site-directed mutagenesis.
Overexpression of Tt-eRF1 was ¢rst tested in E. coli using
the T7 promoter-driven expression system. Though the
amount of synthesized Tt-eRF1 reached one third of the total
proteins, the recombinant Tt-eRF1 was fully insoluble in spite
of any trials (data not shown). The aggregated Tt-eRF1 was
solubilized and isolated in denaturing conditions to homoge-
neity and used to prepare the rabbit antibody. The resulting
anti-Tt-eRF1 antibody detected a single major protein band
with a molecular mass of 49^50 kDa by Western blot analysis
of Tetrahymena total protein (see Fig. 3B, lane 1). These im-
munostaining data indicate that the cloned gene is expressed
in Tetrahymena and encodes a unique protein whose mass is
consistent with that predicted by the DNA sequence.
Fig. 2. Complex formation between Tetrahymena eRF1 and S.
pombe eRF3 fused to GST. Proteins were mixed in equimolar
amounts, and those bound to the immobilized-eRF3* beads were
eluted from the beads by adding excess glutathione. A: Binding of
Tt-eRF1 to GST-Sp-eRF3*. B: Control experiment on binding of
Tt-eRF1 to glutathione Sepharose in the absence of Sp-eRF3*.
Lanes: 1, samples before binding to glutathione Sepharose; 2, un-
bound protein; 3 and 4, wash; 5, eluted protein. Samples were ana-
lyzed by SDS-PAGE and Western blotting using anti-Tt-eRF1 anti-
body.
Fig. 3. Subcellular fractionation of Tetrahymena eRF1 expressed in
S. cerevisiae (A) and T. thermophila (B). Experimental procedures
are described in Section 2. Total cell lysates were subjected to low-
speed centrifugation, and the resulting cleared lysates were fractio-
nated by high-speed centrifugation at 130 000Ug, giving rise to the
ribosomal pellet and the post-ribosomal supernatant. Lanes: 1, total
lysate; 2, cleared lysate; 3, post-ribosomal supernatant; 4, ribo-
somes. The equal volume of fractions derived from the same cell
samples was analyzed by SDS-PAGE and Western blot using anti-
Tt-eRF1 antibody.
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In the course of screening for a soluble form of Tt-eRF1,
we found that the heterologous expression of Tt-eRF1 in S.
cerevisiae yielded a soluble fraction of Tt-eRF1 in cell lysates
though the expression level was very low. The protein was
puri¢ed to homogeneity by three steps of a⁄nity and anion
exchange chromatography using Ni-NTA agarose, heparin
Toyopearl and Mono Q columns. Puri¢ed soluble recombi-
nant Tt-eRF1 showed a molecular mass of 49^50 kDa and
comigrated identically with the authentic Tt-eRF1.
The ability to terminate protein synthesis of the puri¢ed Tt-
eRF1 was monitored by the rate of N-formylmethionine
(fMet) release at the UGA codon from the in vitro termina-
tion complex composed of f[3H]Met-tRNAf , AUG, UGA-
AAAAA, and the ribosome isolated from rat or Artemia
according to the published procedures [22]. While the S.
pombe or rabbit eRF1 protein exerted release activity in this
system, Tt-eRF1 failed to catalyze fMet release (data not
shown).
3.3. Heterodimer complex between Tetrahymena eRF1 and S.
pombe eRF3
To assess the reason for disability of Tt-eRF1 in the in vitro
termination reaction, we examined the protein activity to in-
teract with other components. Recombinant eRF1 and eRF3
(or its N-terminally truncated EF-1K-like polypeptide, re-
ferred to as eRF3* [20]) from di¡erent eukaryotes are known
to bind in vivo and in vitro [20,21,23,24]. To test if the cloned
Tt-eRF1 possesses the activity to bind to heterologous eRF3,
pull-down analysis was carried out in vitro using the puri¢ed
recombinant eRF3* of S. pombe (referred to as Sp-eRF3*)
and Tt-eRF1. Protein complexes with Sp-eRF3* fusion to
GST were immobilized onto glutathione-agarose beads, pre-
cipitated, and washed with bu¡er to remove non-speci¢c pro-
teins. Bound proteins were eluted and analyzed by Western
blotting using anti-Tt-eRF1 antibody. When the two compo-
nents, Tt-eRF1 and Sp-eRF3*, were mixed, immobilized Sp-
eRF3* e⁄ciently precipitated Tt-eRF1 as shown in the West-
ern blot (Fig. 2A, lane 5). In the absence of eRF3*, the resin
failed to precipitate Tt-eRF1 (negative control ; Fig. 2B, lane
5). The binding activity of Tt-eRF1 to S. pombe eRF3 seemed
to be strong since its binding was not e⁄ciently competed by
20^25 molar excess amount of an N-terminally truncated
eRF1 polypeptide, Sp-eRF1-vN2 [20], that retains su⁄cient
activity for binding to Sp-eRF3* in vivo and in vitro (data not
shown).
3.4. Subcellular localization of Tetrahymena eRF1 in yeast
and Tetrahymena cells
It is known that de novo synthesized eRF1 and eRF3 pro-
teins of S. cerevisiae as well as Xenopus eRF1 expressed in S.
cerevisiae are found almost exclusively bound to the ribosome
[25^27]. Based on the subcellular fractionation and the detec-
tion by anti-Tt-eRF1 antibody, we also found that the major-
ity of de novo Tt-eRF1 was bound to the ribosome in Tetra-
hymena cells and little Tt-eRF1 was detected in the post-
ribosomal supernatant (Fig. 3B; compare lanes 3 and 4).
The Tt-eRF1 was tightly associated with the Tetrahymena
ribosome and released only partly even by washing with 1 M
NH4Cl (data not shown). In contrast to the de novo Tt-eRF1,
the recombinant Tt-eRF1 expressed in S. cerevisiae was
bound to the ribosome only partly (Fig. 3A; compare lanes
3 and 4), suggesting that Tt-eRF1 binds much less e⁄ciently
to heterologous ribosomes such as yeast ribosomes. We
assumed that the lack of e¡ective binding to the heterologous
ribosome of Tt-eRF1 might, at least in part, account for the
inability of Tetrahymena eRF1 to catalyze polypeptide release
in vitro.
The lack of e⁄cient interaction of Tt-eRF1 with the heter-
ologous ribosome is conceivable from the large phylogenetic
distance of Tt-eRF1 from other eukaryotic eRF1s (Fig. 4). It
is quite remarkable that Tt-eRF1 is very isolated from most
other eRF1s in the phylogenetic tree, showing only 53^57%
identity to mammalian and yeast eRF1s. Therefore, one could
argue that Tt-eRF1 might have evolved rapidly compared
with other eRF1s. It remains to be examined whether eRF1
genes from other ciliates are also distantly related to the mam-
malian release factor genes.
4. Discussion
The ¢rst release factor gene of ciliates was cloned from
Tetrahymena in this work. Several lines of evidence support
that the cloned sequence encodes eRF1 and originated from
Tetrahymena. First, the predicted ORF contains multiple
UAA and UAG triplets that are assigned as a glutamine co-
don in Tetrahymena. Second, the cloned sequence uniquely
Fig. 4. Phylogenetic tree of the eukaryotic and archaebacterial release factors adopted from the public databases and this study.
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hybridized to Tetrahymena DNA but not to others. Third, the
raised antibody detected a single major protein of Tetrahyme-
na. Fourth, the deduced protein sequence is highly homolo-
gous to other eukaryotic and archaebacterial release factors
(see Fig. 1). Fifth, the recombinant protein is able to bind to
yeast eRF3 in vitro (see Fig. 2) and associated with the ribo-
some in vivo (see Fig. 3).
Sequence comparison of Tt-eRF1 with known eRF1s dem-
onstrates its conservative primary sequence throughout do-
mains A^G that have been assigned as seven conserved do-
mains in prokaryotic and eukaryotic RFs [6] (see Fig. 1). We
have predicted that domains C and D play important roles in
stop codon recognition [5,6,10]. In view of this prediction, it is
rather surprising that these two domains of Tt-eRF1 are
highly conservative and contain only a few residues that are
unique to Tt-eRF1. This limited number of distinct residues
would not be su⁄cient to confer the strict and sole speci¢city
to UGA on Tt-eRF1, although they might be able to confer
some (relaxed) preference to UGA compared with the other
two if any.
In spite of the overall conservative protein structure of Tt-
eRF1 compared with mammalian and yeast eRF1s, the solu-
ble recombinant Tt-eRF1 did not show any polypeptide re-
lease activity in vitro using rat or Artemia ribosomes. As al-
ready mentioned above, this disability may be due to the
heterologous translation system using heterologous ribo-
somes, with which Tt-eRF1 is associated much less e⁄ciently
compared with Tetrahymena ribosome (see Fig. 3). This view
is supported by the distant phylogenetic position of Tt-eRF1
compared with other eRF1s (see Fig. 4). It is noteworthy that
most known eRF1s from di¡erent eukaryotic organisms in-
cluding Xenopus, human and yeast are functionally exchange-
able in vivo and in vitro and that Tt-eRF1 is the ¢rst excep-
tion to this property. There are several cases of functional
disability or limited ability of translational components in
heterologous systems [28^30]. It is also known that mutational
defects in binding to the ribosome of S. cerevisiae release
factors led to termination defects [31] and gave rise to an
allosuppressor phenotype [27,32]. The observed weak binding
of Tt-eRF1 to heterologous ribosomes might be correlated
with the sequence diversity of Tt-eRF1 in its N-terminal (do-
mains A/B) and C-terminal (domains E/F) regions (see Fig. 1).
Recently, it has been suggested that initial (primary) binding
to the ribosome of bacterial RF1 and RF2 is catalyzed by N-
terminal domains A/B [33]. We assume that the less conserva-
tive nature of the N-terminal of Tt-eRF1 could be due to its
binding site property of Tetrahymena ribosomes, which might
be more diverse than others. This prediction might account
for the reduced a⁄nity of Tt-eRF1 to heterologous ribosomes
(see Fig. 3).
Given that Tt-eRF1 possesses potentially omnipotent rec-
ognition capacity, other element(s) in Tt-eRF1 domains or in
the Tetrahymena ribosome might function to confer UGA
speci¢city on Tt-eRF1 or to block termination at UAA and
UAG. One could speculate that some mRNA context around
in-frame UAA and UAG may function as such a cis element.
It is known that three stop codons are not used randomly or
equitably in the database and the base following the triplet
greatly in£uences the usage frequency in both prokaryotes
and eukaryotes [34,35]. For example, six of eight possible
tetranucleotides starting with UAA and UAG are frequently
used, but the two sequences, UAGC and UAGU, are used
very rarely if at all in eukaryotes [35]. The rarely used stop
signals represent those that can be recognized weakly by re-
lease factors [36,37], thus providing a clue to weaken polypep-
tide termination and increase suppression by tRNA by com-
petition. We scored the usage of UAAN and UAGN coding
tetranucleotides in 20 known cDNA sequences of Tetrahyme-
na. Of 87 UAGN cases, there is no apparent tetranucleotide
bias: 32 UAGAs, 22 UAGGs, 20 UAGCs, and 13 UAGUs.
Therefore, we assume that frequent use of the rare (and weak)
tetranucleotides UAGC and UAGU might contribute, at least
in part, to enhanced assignment of glutamine by two gluta-
minyl-tRNAs cognate to UAA and/or UAG [14,15] in Tetra-
hymena even if Tt-eRF1 is capable of reading UAA and
UAG.
Apparently, the in vitro termination system directed by the
Tetrahymena ribosome remains to be established to answer
the key question of whether Tt-eRF1 reads only UGA or
UAA/UAG as well. Alternatively, genetic manipulation or
selection for a Tt-eRF1 derivative that is active with heterol-
ogous ribosomes in vitro or complements a temperature-sen-
sitive eRF1 mutation of S. cerevisiae should provide us with a
powerful tool to facilitate the analysis.
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